Site-specific human papillomavirus infection in adolescent men who have sex with men (HYPER): an observational cohort study.

[1]  Deborah Bateson,et al.  Assessment of herd immunity and cross-protection after a human papillomavirus vaccination programme in Australia: a repeat cross-sectional study. , 2014, The Lancet. Infectious diseases.

[2]  B. Clotet,et al.  Oral human papillomavirus type-specific infection in HIV-infected men: a prospective cohort study among men who have sex with men and heterosexual men. , 2014, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[3]  S. Garland,et al.  Sexual behaviors and risk for sexually transmitted infections among teenage men who have sex with men. , 2014, The Journal of adolescent health : official publication of the Society for Adolescent Medicine.

[4]  S. Garland,et al.  How very young men who have sex with men view vaccination against human papillomavirus. , 2014, Vaccine.

[5]  S. Garland,et al.  Early acquisition of anogenital human papillomavirus among teenage men who have sex with men. , 2014, The Journal of infectious diseases.

[6]  M. Golden,et al.  High rates of incident and prevalent anal human papillomavirus infection among young men who have sex with men. , 2014, The Journal of infectious diseases.

[7]  J. Palefsky,et al.  Anal Human Papillomavirus Infection Among Thai Men Who Have Sex With Men With and Without HIV Infection: Prevalence, Incidence, and Persistence , 2013, Journal of acquired immune deficiency syndromes.

[8]  B. Clotet,et al.  Prevalence, Clearance, and Incidence of Human Papillomavirus Type–Specific Infection at the Anal and Penile Site of HIV-Infected Men , 2013, Sexually transmitted diseases.

[9]  J. Palefsky,et al.  High prevalence and incidence of high-grade anal intraepithelial neoplasia among young Thai men who have sex with men with and without HIV , 2013, AIDS.

[10]  E. Sugar,et al.  Natural history of anal vs oral HPV infection in HIV-infected men and women. , 2013, The Journal of infectious diseases.

[11]  R. Guy,et al.  Genital warts in young Australians five years into national human papillomavirus vaccination programme: national surveillance data , 2013, BMJ : British Medical Journal.

[12]  B. Clotet,et al.  Natural History of Human Papillomavirus Infections Involving Anal, Penile, and Oral Sites Among HIV-Positive Men , 2013, Sexually transmitted diseases.

[13]  S. Garland,et al.  The prevalence of anal human papillomavirus among young HIV negative men who have sex with men , 2012, BMC Infectious Diseases.

[14]  S. Garland,et al.  Oral Human Papillomavirus in Men Having Sex with Men: Risk-Factors and Sampling , 2012, PloS one.

[15]  B. Clotet,et al.  Condylomata, cytological abnormalities and human papillomavirus infection in the anal canal in HIV‐infected men , 2012, HIV medicine.

[16]  B. Graubard,et al.  Prevalence of oral HPV infection in the United States, 2009-2010. , 2012, JAMA.

[17]  A. Giuliano,et al.  Six-month incidence, persistence, and factors associated with persistence of anal human papillomavirus in men: the HPV in men study. , 2011, The Journal of infectious diseases.

[18]  A. Burchell,et al.  Genital transmission of human papillomavirus in recently formed heterosexual couples. , 2011, The Journal of infectious diseases.

[19]  H. Jessen,et al.  HPV vaccine against anal HPV infection and anal intraepithelial neoplasia. , 2011, The New England journal of medicine.

[20]  L. Dodd,et al.  Evaluation of the Polyclonal ELISA HPV Serology Assay as a Biomarker for Human Papillomavirus Exposure , 2011, Sexually transmitted diseases.

[21]  M. Pawlita,et al.  Lack of type-specific concordance between human papillomavirus (HPV) serology and HPV DNA detection in the uterine cervix and oral mucosa. , 2011, The Journal of general virology.

[22]  Masha Fridman,et al.  Early effect of the HPV vaccination programme on cervical abnormalities in Victoria, Australia: an ecological study , 2011, The Lancet.

[23]  G. Palù,et al.  Anal and oral human papillomavirus (HPV) infection in HIV-infected subjects in northern Italy: a longitudinal cohort study among men who have sex with men , 2011, BMC infectious diseases.

[24]  H. Jessen,et al.  Efficacy of quadrivalent HPV vaccine against HPV Infection and disease in males. , 2011, The New England journal of medicine.

[25]  E. Franco,et al.  Episomal and integrated human papillomavirus type 16 loads and anal intraepithelial neoplasia in HIV-seropositive men , 2010, AIDS.

[26]  P. Coursaget,et al.  Seroprevalence of Antibodies against Human Papillomavirus (HPV) Types 16 and 18 in Four Continents: the International Agency for Research on Cancer HPV Prevalence Surveys , 2010, Cancer Epidemiology, Biomarkers & Prevention.

[27]  M. Schiffman,et al.  Classification of weakly carcinogenic human papillomavirus types: addressing the limits of epidemiology at the borderline , 2009, Infectious Agents and Cancer.

[28]  E. Franco,et al.  Prevalence, clearance, and incidence of anal human papillomavirus infection in HIV-infected men: the HIPVIRG cohort study. , 2009, The Journal of infectious diseases.

[29]  J. Kaldor,et al.  Risk Factors for Genital and Anal Warts in a Prospective Cohort of HIV-Negative Homosexual Men: The HIM Study , 2006, Sexually transmitted diseases.

[30]  A. Osterhaus,et al.  Acquisition and clearance of perianal human papillomavirus infection in relation to HIV-positivity in men who have sex with men in the Netherlands. , 2005, Acta dermato-venereologica.

[31]  M. Pagano,et al.  Skp2, the FoxO1 hunter. , 2005, Cancer cell.

[32]  N. Kiviat,et al.  Genital human papillomavirus infection: incidence and risk factors in a cohort of female university students. , 2003, American journal of epidemiology.

[33]  Almut Scherer,et al.  Mathematical models of vaccination. , 2002, British medical bulletin.

[34]  S. Garland,et al.  Cervical adenoid basal carcinoma, five cases and literature review , 1996 .

[35]  A. Reingold,et al.  Genital human papillomavirus infection in female university students as determined by a PCR‐based method , 1991, JAMA.

[36]  H. Fox,et al.  Detection and typing of human papillomavirus in archival cervical cancer specimens by DNA amplification with consensus primers. , 1990, Journal of the National Cancer Institute.

[37]  K Ulm,et al.  A simple method to calculate the confidence interval of a standardized mortality ratio (SMR) , 1990, American journal of epidemiology.

[38]  H. Jessen,et al.  Prevalence of and risk factors for human papillomavirus (HPV) infection among HIV-seronegative men who have sex with men. , 2011, The Journal of infectious diseases.

[39]  R. Guy,et al.  Quadrivalent human papillomavirus vaccination and trends in genital warts in Australia: analysis of national sentinel surveillance data. , 2011, The Lancet. Infectious diseases.

[40]  O. Diekmann,et al.  On the definition and the computation of the basic reproduction ratio R0 in models for infectious diseases in heterogeneous populations , 1990, Journal of mathematical biology.

[41]  Steven Wolinsky,et al.  The use of polymerase chain reaction amplification for the detection of genital human papillomaviruses , 1989 .